Oxycodone Addiction

Oxycodone grips fast and for many opens the slide toward heroin and fentanyl. How to recognize the signs, reverse an overdose with naloxone, get through withdrawal, and use medication treatment that actually works.

Jessica Miller is the Content Manager of Addiction HelpWritten by
Kent S. Hoffman, D.O. is a founder of Addiction HelpMedically reviewed by Kent S. Hoffman, D.O.
Last updated

Battling addiction & ready for help?

Find Treatment Now

What Oxycodone Is and Why It Takes Hold

Oxycodone is a strong prescription painkiller — the drug inside OxyContin, Percocet, and Roxicodone — and it can grab hold of a person the same way heroin or fentanyl can. If you take it, love someone who does, or found a bottle and got scared, that’s the plain truth to start from.

It is genuinely useful medicine. It is also one of the most misused drugs in American history, and both of those things are true at once.

Two facts sit at the heart of its story. Retail sales climbed 866% between 1997 and 2007[1]. By 2023, nearly 80,000 Americans were dying of opioid-related causes each year[2].

A named problem is a treatable one. If oxycodone has taken more of your life than you meant it to, thousands of people get free of it every year, and the way out is far less painful than the one you’re imagining.

An opioid overdose can be reversed, if you act fast. Naloxone (Narcan) buys the minutes that save a life.
If you or someone you love is in crisis, call or text 988 now. Slow or stopped breathing, blue or gray lips, pinpoint pupils, or someone you cannot wake are signs of an opioid overdose.

What to do:

  • Carry naloxone (Narcan). It reverses an opioid overdose within minutes — give it and call 911, and if oxycodone has a grip on you, get into treatment that fits your life.
  • Get into treatment. Medications like buprenorphine (Suboxone), methadone, and other MAT ease withdrawal and cut the risk of dying — the easier way out, not white-knuckling it alone.
  • Never use alone. If no one is there to give naloxone and call for help, an overdose has no witness — keep someone with you.

Find treatment today →

AddictionHelp.com Fast Facts
  • Oxycodone is a strong Schedule II opioid, the drug inside OxyContin, Percocet, and Roxicodone, and it can grab hold the same way heroin or fentanyl can.
  • The biggest modern danger is the counterfeit pill: fakes pressed with illicit fentanyl look identical to real oxycodone and have killed people who thought they knew their dose.
  • The way out: Medical detox plus medication makes withdrawal manageable, not the agony people fear.

The Oxycodone Family — OxyContin, Percocet, and Roxicodone

People hear several different names and assume they’re different drugs. They all contain the same active ingredient — oxycodone — but they’re built differently, and the differences matter.

  • OxyContin — the extended-release version, designed to release oxycodone slowly over about 12 hours for around-the-clock pain. It was reformulated in 2010 to resist crushing.
  • Percocet — pairs oxycodone with acetaminophen (the drug in Tylenol). It works fast and wears off in four to six hours, but the acetaminophen caps how much a person can safely take, because too much harms the liver.
  • Roxicodone — plain immediate-release oxycodone without acetaminophen, used for acute pain and breakthrough pain.
  • Generics — both immediate- and extended-release versions are widely available and work the same as the brands.

One specialized product, oxycodone/naloxone prolonged-release (OXN PR), adds a small amount of naloxone to fight the constipation that long-term opioids cause. It eases the gut without weakening pain relief[3][4].

Whatever the brand on the bottle, the opioid inside carries the same potential to relieve pain and to take hold. For the wider family of pills, from hydrocodone to morphine, start with prescription opioids.

How Oxycodone Works in the Brain

Oxycodone is a semi-synthetic opioid made from thebaine, a compound in the opium poppy, first created back in 1916[5]. More than a century later, the way it works is well understood.

Oxycodone Switches on the Brain’s Reward Circuit

Oxycodone’s main target is the mu-opioid receptor, the same switch morphine and heroin flip[5]. Turning it on relieves pain — and produces the warm, drowsy relief that makes opioids so easy to crave[6].

Take it long enough and those receptors adapt, and that adaptation is what drives tolerance and physical dependence[7]. Addiction isn’t a character flaw. Opioids physically rewire the brain’s reward and stress systems, which is why stopping feels impossible alone and why medical help works so much better[8].

How the Body Breaks Oxycodone Down

The liver clears oxycodone through two enzyme routes, and one of them creates a stronger byproduct:

  • CYP3A4 (the major route) turns oxycodone into noroxycodone.
  • CYP2D6 (the minor route) turns it into oxymorphone, a more potent active metabolite.

Even so, oxymorphone shows up in the brain at only about 1/250th the level of oxycodone itself, so the parent drug does most of the work[9].

How CBD Can Triple Oxycodone Levels

Anything that slows those enzymes can quietly push oxycodone levels up. The clearest example surprises people: CBD.

In animal research, CBD raised total oxycodone exposure three-fold and lifted peak levels by 50%[10]. Someone taking their normal prescribed dose alongside CBD oils or gummies can end up with far more drug in their system than they bargained for. If you use CBD in any form, tell your prescriber.

Why Oxycodone Is So Easy to Get Hooked On

Oxycodone has a reputation for producing a powerful high, and the science backs it up. It rates unusually high on what researchers call “liking” and “wanting” — the two pulls that make a drug hard to put down[1].

Did you know?

Not everyone is pulled equally hard. In large animal studies, the individuals who got the most pain relief from their first doses went on to show the most addiction-like behavior — initial response accounted for roughly 40% of the difference in how fast use escalated[11]. The person who feels the biggest relief may also be the one most at risk.

This is why two people can take the same prescription and walk away with very different stories. One develops ordinary, expected dependence. Another finds the drug has hooked something deeper. Neither outcome is a moral verdict — but knowing the risk is real lets you watch for it instead of being blindsided.

Tolerance, Dependence, and Addiction Are Three Different Things

Tolerance vs. dependenceTolerance means a dose stops doing what it used to, so the body asks for more. Dependence means the body has settled around the drug and protests when it’s gone. Neither one, on its own, is addiction.

This is the distinction that matters most if you take oxycodone for real pain. People use these three words as if they mean the same thing. They don’t.

  • Tolerance — the same dose does less over time, so you need more for the same relief.
  • Physical dependence — your body has adjusted, so stopping suddenly brings withdrawal.
  • Addiction — compulsive use you can’t rein in, craving, and using despite the damage.

Tolerance and dependence don’t mean you’re addicted[12]. They are normal, expected responses to taking any opioid for a while. A pain patient who takes oxycodone as prescribed and doesn’t chase extra doses has tolerance and dependence, not addiction; clinically, they look different from people in addiction treatment[13].

Being treated like an addict in that situation is wrong, and it does real harm. The line gets crossed somewhere else — and it helps to know exactly where.

The Line Where Dependence Crosses into Addiction

In chronic-pain patients, the clinical warning signs that dependence is tipping over into a problem are[14]:

  • Growing tolerance — needing more for the same relief
  • Withdrawal between doses
  • Craving — the urge that takes on a life of its own

Then there are the behaviors people recognize in themselves:

  • Taking more than prescribed
  • Crushing or snorting pills
  • Using someone else’s script
  • Buying it elsewhere
  • Organizing your day around the next dose

When use looks like that, dependence has become addiction — and that’s the moment to reach for help, not to hide.

For a fuller picture of where that line sits, understand addiction versus physical dependence.

The OxyContin Marketing Story that Started a Crisis

You can’t understand oxycodone without understanding how it flooded the country. This isn’t a side note — it’s the reason a useful painkiller became a household catastrophe.

When Purdue Pharma launched OxyContin in 1996, it sold doctors a central claim: that the extended-release design made the drug less addictive, because it released slowly and dulled the rush. That claim was false. The slow-release coating was easily defeated by crushing the tablet, and sales exploded — that 866% jump between 1997 and 2007[1].

The numbers tell the rest:

  • Oxycodone distributed per person rose 280% from 2000 to 2010[15].
  • At the peak there was a 15-fold gap between the highest- and lowest-prescribing states[15].
  • Opioid-related deaths climbed 806% from 2000 to 2021[15].

This wasn’t a natural response to unmet medical need. It was the result of a deliberate, deceptive campaign — and it built a large population of people dependent on opioids, which set the stage for everything that came next.

From Pills to Heroin to Fentanyl

The crisis didn’t stay put. It moved, in a cascade that’s now well documented — and it explains why a prescription that felt safe could end somewhere terrifying.

The 2010 Reformulation Pushed People Toward Heroin

What 'reformulation' meansReformulating a pill means rebuilding it so it’s harder to crush, snort, or inject — the same medicine inside, wrapped in a tougher shell. It changes how a drug can be misused, not whether someone still needs it.

When OxyContin was reformulated in 2010 to resist crushing, it disrupted the supply of easily abused pills. But demand didn’t disappear — it moved.

After the change:

  • Abuse of reformulated extended-release oxycodone fell 36%[16].
  • Abuse of other oxycodone rose 20%[16].
  • Heroin exposures rose 42%[16].

Among New York City patients who had been filling steady oxycodone 80 mg prescriptions, 40% switched to other opioids afterward, and researchers concluded the abrupt loss of supply “prompted many to transition to heroin in order to avoid severe withdrawal”[17].

The reformulation reduced misuse of one product. It did not reduce the need. As one research team put it, “efforts to reduce supply alone will not mitigate the opioid abuse problem in this country”[18].

Counterfeit Pills Are Today’s Deadliest Trap

As heroin spread, suppliers began cutting and then replacing it with illicit fentanyl — far cheaper and far stronger. Now that fentanyl is pressed into counterfeit oxycodone pills that look exactly like the real thing[19].

The single most important safety rule today is simple: never take a pill that didn’t come from your pharmacy with your name on it. A tablet bought from a friend, a dealer, or online can carry a fatal dose of fentanyl with no warning[19]. Learn more about fentanyl in counterfeit pills.

When Oxycodone Is the Right Choice for Pain

With all of that on the table, why would any doctor prescribe oxycodone? Because for the right patient, it’s effective, well-studied medicine.

Surgical and Cancer Pain Are the Clearest Reasons

For short-term, moderate-to-severe pain, oxycodone earns its place. In a trial of pain after cesarean section, oral oxycodone worked better than IV morphine — lower pain scores, less total opioid used, and fewer side effects[20].

It’s also a mainstay in cancer and palliative care, where the oxycodone/naloxone combination has been studied specifically to control pain while easing the constipation opioids cause[21].

In those settings, oxycodone is one part of a broader plan — combined with non-opioid medicines, physical therapy, and support, not leaned on alone. Using it carefully for real pain is not the same as the misuse that drove the crisis.

What Oxycodone Withdrawal Feels Like

Here’s the fear that keeps people stuck. The withdrawal in your head — the sweats, the sickness, the crawling skin — is what stopping looks like when someone tries to power through alone. That’s not the only path, and it’s not the one to choose.

For immediate-release oxycodone, withdrawal usually starts 6 to 12 hours after the last dose, peaks around 36 to 72 hours, and eases within a week, though sleep and mood can take longer to settle.

Common symptoms include:

  • Muscle aches and restlessness
  • Sweating, runny nose, and goosebumps
  • Nausea, vomiting, and diarrhea
  • Anxiety and insomnia

Opioid withdrawal is rarely life-threatening for an otherwise healthy adult, but it is intensely uncomfortable — and that misery is exactly what drives people back to use, or toward street opioids[22][17]. For a day-by-day picture, follow the prescription opioid withdrawal timeline.

Did you know?

Withdrawal is the trap, not the cure. The discomfort of stopping cold is one of the biggest reasons people relapse — which is the whole point of medical detox. The right medication makes that stretch manageable, so you never have to face the worst of it on your own[23].

How to Stop Taking Oxycodone Safely

This is the part that matters most if oxycodone has a grip on you. The way out is far easier than the withdrawal you’re dreading, and the life on the other side is better than the one you’re protecting right now.

Medication Makes Withdrawal Manageable

MAT, in plain wordsMAT stands for medication for opioid use disorder. It’s not trading one addiction for another — it’s using a prescribed medicine to quiet cravings and steady the body so recovery has a fighting chance.

If oxycodone use has crossed into addiction, the evidence-based standard isn’t willpower or going it alone — it’s medication for opioid use disorder, the safe path through.

  • Buprenorphine (Suboxone) — a partial opioid that calms cravings and withdrawal without the full high, and it sharply cuts the risk of dying[23]. In animal models, buprenorphine reliably reduces oxycodone-seeking[24].
  • Methadone — given through licensed programs, it has the longest track record of any of these medicines and works well for severe addiction.
  • Naltrexone (Vivitrol) — blocks opioid effects entirely, an option once withdrawal is complete.

A slow, structured taper is also a recognized way to come off opioids with the least possible suffering, especially for someone who became dependent through legitimate treatment[25].

The Receptors Settle, and Life Comes Back

The picture in your head isn’t the whole story. The receptors that oxycodone rewired settle back down, and people who felt certain they could never stop get their footing, their relationships, and their mornings back.

If you’re a long-term pain patient, dependence doesn’t make you an addict, and no one should force you off a medicine that’s working. Ask your prescriber about keeping naloxone (Narcan) on hand — it’s a safety measure, like a fire extinguisher, not an accusation.

Getting Help for Oxycodone Addiction

Oxycodone is serious medicine with a serious history, and its most dangerous trap today is the counterfeit pill that hides fentanyl. Whether you take it for pain and worry it’s slipping out of control, or you’ve been misusing it and are tired of the fear, the message is the same: this is treatable, the path out is gentler than you expect, and naloxone (Narcan) keeps an overdose from becoming the end of the story.

Recognizing the problem isn’t the bottom. It’s the turn. For the wider family of pills it belongs to, start with prescription opioids.

The next step doesn’t have to be a big one. Our treatment centers directory can point you to the right level of care. Reaching out today is a real step forward — and one you can make right now.

Frequently asked questions

Is oxycodone the same as OxyContin and Percocet?

Oxycodone is the active drug; OxyContin, Percocet, and Roxicodone are brand names for it. OxyContin is the extended-release form built to last about 12 hours. Percocet combines oxycodone with acetaminophen (the ingredient in Tylenol) and is immediate-release, which is why it also carries a liver-damage risk if you take too much. Roxicodone is immediate-release oxycodone without the acetaminophen. Generic versions of all of these exist and work the same way. They are all the same core opioid[5].

Why is oxycodone so addictive?

Oxycodone acts on the brain’s mu-opioid receptors, the same system that controls both pain relief and reward, and it produces an unusually strong pull. Researchers measured it as scoring high on both “liking” (pleasure) and “wanting” (craving), a combination that makes its abuse potential especially steep[1]. Its pharmacology is genuinely distinct from morphine’s, not just a milder or stronger version[26]. Vulnerability also varies from person to person: in research, the people who got the most relief from an early dose were among the most likely to develop addiction-like behavior later[11]. That is biology, not weakness.

Am I addicted to oxycodone, or just physically dependent?

They are different things, and the difference matters. Physical dependence means your body has adapted to the drug, so stopping abruptly causes withdrawal. If you’ve taken oxycodone for genuine pain on a stable dose for a while, you’re probably dependent, and that alone does not make you addicted. Addiction, clinically called opioid use disorder, is the compulsion: cravings, loss of control, and continuing to use despite real harm. The signs include taking more than prescribed, early refills, using to manage emotions rather than pain, trying to cut down and failing, and using in ways other than prescribed. A handful of those showing up together over time is the signal to get evaluated.

Will I end up using heroin or fentanyl?

Not everyone does, but the slide is common enough that it’s worth knowing about. When prescriptions end or get cut off, the withdrawal can be severe enough to send people looking for relief elsewhere. After OxyContin was reformulated in 2010 to resist crushing, heroin exposures rose 42% as demand shifted[16], and one study found steep dose cuts “prompted many to transition to heroin in order to avoid severe withdrawal”[17]. Today much of the street supply contains illicit fentanyl, often in counterfeit pills made to look exactly like real oxycodone. That’s why two rules matter most: never take a pill that didn’t come from a licensed pharmacy, and keep naloxone (Narcan) on hand.

How bad is oxycodone withdrawal, and is detox dangerous?

Oxycodone withdrawal usually begins 6 to 12 hours after the last dose, peaks around 36 to 72 hours, and eases over about a week, though sleep and mood can take longer. It feels like a severe flu crossed with deep restlessness: aching, sweating, nausea, diarrhea, and relentless anxiety. It’s miserable, but rarely dangerous in an otherwise healthy adult. The important part is that you don’t have to endure raw withdrawal at all. Medical detox exists so you don’t, and medications like buprenorphine (Suboxone) and methadone take the agony off the table and make the whole process manageable. Doing it with medical help is both the safe way and the far more comfortable one.

What's the most effective treatment for oxycodone addiction?

The evidence-based standard is medication for opioid use disorder, not detox alone or willpower. Buprenorphine (Suboxone, Subutex, Sublocade) is usually the first option; it quiets cravings and withdrawal without the full high and sharply lowers the risk of overdose death, and newer methods can start it without first putting you through full withdrawal. Methadone, dispensed through licensed programs, is a long-proven option especially for severe addiction. Naltrexone (the Vivitrol shot) blocks opioids entirely for people who have already detoxed. These medications are not “trading one addiction for another”, they’re medicine that keeps people alive and functioning while the rest of recovery takes hold. You can reach free, confidential help any time at SAMHSA’s National Helpline, 1-800-662-HELP (4357).

Get Treatment Help

If you or someone you love is struggling with addiction, getting help is just a phone call away, or consider trying therapy online with BetterHelp.

Exclusive offer: 20% Off BetterHelp*

Following links to the BetterHelp website may earn us a commission that helps us manage and maintain AddictionHelp.com. *Get 20% off your first month of BetterHelp. Offer valid for new BetterHelp users only. Offer cannot be combined with insurance.

26 Sources
  1. Kibaly, Cherkaouia, Alderete, Jacob A, Liu, Steven H, Nasef, Hazem S, Law, Ping-Yee, Evans, Christopher J, Cahill, Catherine M (2021). Oxycodone in the Opioid Epidemic: High 'Liking', 'Wanting', and Abuse Liability. Cellular and molecular neurobiology. https://doi.org/10.1007/s10571-020-01013-y
  2. Solgama, Jay P, Pradhan, Apoorva, McCall, Kenneth L, Piper, Brian J (2026). Pharmacoepidemiology of Oxycodone in the USA: An Observational Study of ARCOS, Medicaid, and Medicare Drug Databases. Pharmacology research & perspectives. https://doi.org/10.1002/prp2.70210
  3. Kim, Esther S (2017). Oxycodone/Naloxone Prolonged Release: A Review in Severe Chronic Pain. Clinical drug investigation. https://doi.org/10.1007/s40261-017-0593-1
  4. Leppert, Wojciech, Zajaczkowska, Renata, Wordliczek, Jerzy (2019). The role of oxycodone/naloxone in the management of patients with pain and opioid-induced constipation. Expert opinion on pharmacotherapy. https://doi.org/10.1080/14656566.2018.1561863
  5. Barrett, James E, Shekarabi, Aryan, Inan, Saadet (2023). Oxycodone: A Current Perspective on Its Pharmacology, Abuse, and Pharmacotherapeutic Developments. Pharmacological reviews. https://doi.org/10.1124/pharmrev.121.000506
  6. Pasternak, Gavril W (2018). Mu Opioid Pharmacology: 40 Years to the Promised Land. Advances in pharmacology (San Diego, Calif.). https://doi.org/10.1016/bs.apha.2017.09.006
  7. Swingler, Michael, Donadoni, Martina, Unterwald, Ellen M, Maggirwar, Sanjay B, Sariyer, Ilker K (2025). Molecular and cellular basis of mu-opioid receptor signaling: mechanisms underlying tolerance and dependence development. Frontiers in neuroscience. https://doi.org/10.3389/fnins.2025.1597922
  8. Carroll Turpin, Michelle A, Starks, Steven M, Grissom, Maureen O, Reed, Brian C (2024). Addiction Medicine: Opioid Use Disorder. FP essentials.
  9. Rashvand, Mina, Funk, Douglas, Fletcher, Paul J, Miksys, Sharon, Tyndale, Rachel F (2025). Evaluating the reinforcing properties of oxycodone and oxymorphone using intravenous drug self-administration in male rats. Neuropharmacology. https://doi.org/10.1016/j.neuropharm.2025.110698
  10. Scicluna, Rhianne L, Kang, James W M, Everett, Nicholas A, Badolato, Connie J, Etchart, Maia G, Kevin, Richard C, Wilson, Bianca B, Boorman, Damien C, Gordon, Rebecca S, Anderson, Lyndsey L, Arnold, Jonathon C, Keay, Kevin A, Bowen, Michael T (2026). Behavioural, pharmacokinetic, and genetic evidence of a cannabidiol-oxycodone drug-drug interaction in mice. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. https://doi.org/10.1016/j.biopha.2026.119277
  11. Kallupi, Marsida, de Guglielmo, Giordano, Carrette, Lieselot L G, Simpson, Sierra, Kononoff, Jenni, Kimbrough, Adam, Smith, Lauren C, Shankar, Kokila, Avelar, Alicia, Conlisk, Dana, Brennan, Molly, Tieu, Lani, Sedighim, Sharona, Boomhower, Brent, Maturin, Lisa, Fannon, McKenzie J, Martinez, Angelica, Crook, Caitlin, Dirik, Selen, Velarde, Nathan, Schweitzer, Paul, Bonnet-Zahedi, Selene, Sneddon, Elizabeth, Plasil, Sonja, Morgan, Alex A, Othman, Dyar N, Sichel, Benjamin, Peng, Beverly, Chitre, Apurva S, Polesskaya, Oksana, Lau, Justin, Vang, Ashley, Solberg Woods, Leah C, Palmer, Abraham A, George, Olivier (2026). Large-scale behavioral characterization of oxycodone self-administration in heterogeneous stock rats reveals initial analgesic effects are associated with addiction-like behaviors. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. https://doi.org/10.1038/s41386-026-02348-8
  12. Pohl, Mel, Smith, Logan (2012). Chronic pain and addiction: challenging co-occurring disorders. Journal of psychoactive drugs. https://doi.org/10.1080/02791072.2012.684621
  13. McDonough, Mike, Johnson, Jacinta L, White, Jason M, Buisman-Pijlman, Femke T A (2019). Measuring opioid dependence in chronic pain patients: A comparison between addiction clinic and pain clinic patient populations. Journal of opioid management. https://doi.org/10.5055/jom.2019.0514
  14. Rodríguez-Espinosa, Sara, Coloma-Carmona, Ainhoa, Pérez-Carbonell, Ana, Román-Quiles, José Francisco, Carballo, José Luis (2024). Tolerance, interdose withdrawal symptoms, and craving predict prescription opioid-use disorder severity in chronic pain patients: A three-wave prospective study. Psychiatry research. https://doi.org/10.1016/j.psychres.2024.116241
  15. Solgama, Jay P, Liu, Edward, Davis, Mellar, Graham, Jove, McCall, Kenneth L, Piper, Brian J (2024). State-level variation in distribution of oxycodone and opioid-related deaths from 2000 to 2021: an ecological study of ARCOS and CDC WONDER data in the USA. BMJ open. https://doi.org/10.1136/bmjopen-2023-073765
  16. Coplan, Paul M, Kale, Hrishikesh, Sandstrom, Lauren, Landau, Craig, Chilcoat, Howard D (2013). Changes in oxycodone and heroin exposures in the National Poison Data System after introduction of extended-release oxycodone with abuse-deterrent characteristics. Pharmacoepidemiology and drug safety. https://doi.org/10.1002/pds.3522
  17. Nolan, Michelle L, Harocopos, Alex, Allen, Bennett, Paone, Denise (2020). Reformulation of oxycodone 80 mg to prevent misuse: A cohort study assessing the impact of a supply-side intervention. The International journal on drug policy. https://doi.org/10.1016/j.drugpo.2020.102848
  18. Cicero, Theodore J, Ellis, Matthew S (2015). Abuse-Deterrent Formulations and the Prescription Opioid Abuse Epidemic in the United States: Lessons Learned From OxyContin. JAMA psychiatry. https://doi.org/10.1001/jamapsychiatry.2014.3043
  19. Hartmann, Grace E, Sethi, Roopa (2023). The Role of Non-Pharmaceutical Fentanyl-Contaminated Counterfeit Oxycodone in Increasing Opioid Overdoses: A Commentary Review. The primary care companion for CNS disorders. https://doi.org/10.4088/pcc.22nr03433
  20. Niklasson, Boel, Arnelo, Catarina, Öhman, Susanne Georgsson, Segerdahl, Märta, Blanck, Agneta (2015). Oral oxycodone for pain after caesarean section: A randomized comparison with nurse-administered IV morphine in a pragmatic study. Scandinavian journal of pain. https://doi.org/10.1016/j.sjpain.2015.01.003
  21. Wong, Aaron K, Grobler, Anneke, Le, Brian (2022). ENhANCE trial protocol: A multi-centre, randomised, phase IV trial comparing the efficacy of oxycodone/naloxone prolonged release (OXN PR) versus oxycodone prolonged release (Oxy PR) tablets in patients with advanced cancer. Contemporary clinical trials communications. https://doi.org/10.1016/j.conctc.2022.101036
  22. Simpson, Kelsey A, Bolshakova, Maria, Kirkpatrick, Matthew G, Davis, Jordan P, Cho, Junhan, Barrington-Trimis, Jessica, Kral, Alex H, Bluthenthal, Ricky N (2024). Characterizing Opioid Withdrawal Experiences and Consequences Among a Community Sample of People Who Use Opioids. Substance use & misuse. https://doi.org/10.1080/10826084.2024.2306221
  23. Gowing, Linda, Ali, Robert, White, Jason M, Mbewe, Dalitso (2017). Buprenorphine for managing opioid withdrawal. The Cochrane database of systematic reviews. https://doi.org/10.1002/14651858.cd002025.pub5
  24. Bossert, Jennifer M, Kiyatkin, Eugene A, Korah, Hannah, Hoots, Jennifer K, Afzal, Anum, Perekopskiy, David, Thomas, Shruthi, Fredriksson, Ida, Blough, Bruce E, Negus, S Stevens, Epstein, David H, Shaham, Yavin (2020). In a Rat Model of Opioid Maintenance, the G Protein-Biased Mu Opioid Receptor Agonist TRV130 Decreases Relapse to Oxycodone Seeking and Taking and Prevents Oxycodone-Induced Brain Hypoxia. Biological psychiatry. https://doi.org/10.1016/j.biopsych.2020.02.014
  25. Amato, Laura, Davoli, Marina, Minozzi, Silvia, Ferroni, Eliana, Ali, Robert, Ferri, Marica (2013). Methadone at tapered doses for the management of opioid withdrawal. The Cochrane database of systematic reviews. https://doi.org/10.1002/14651858.cd003409.pub4
  26. Nielsen, C. K., Ross, F. B., Lotfipour, S., Saini, K. S., Edwards, S. R., & Smith, M. T. (2007). Oxycodone and morphine have distinctly different pharmacological profiles: radioligand binding and behavioural studies in two rat models of neuropathic pain. Pain, 132(3), 289-300. https://doi.org/10.1016/j.pain.2007.03.022
Written by
Jessica Miller is the Content Manager of Addiction Help

Editorial Director

Jessica Miller is the Editorial Director of Addiction Help. Jessica graduated from the University of South Florida (USF) with an English degree and combines her writing expertise and passion for helping others to deliver reliable information to those impacted by addiction. Informed by her personal journey to recovery and support of loved ones in sobriety, Jessica's empathetic and authentic approach resonates deeply with the Addiction Help community.

Reviewed by
  • Fact-Checked
  • Editor
Kent S. Hoffman, D.O. is a founder of Addiction Help

Co-Founder & Chief Medical Officer

Kent S. Hoffman, D.O. has been an expert in addiction medicine for more than 15 years. In addition to managing a successful family medical practice, Dr. Hoffman is board certified in addiction medicine by the American Osteopathic Academy of Addiction Medicine (AOAAM). Dr. Hoffman has successfully treated hundreds of patients battling addiction. Dr. Hoffman is the Co-Founder and Chief Medical Officer of AddictionHelp.com and ensures the website’s medical content and messaging quality.

Real Help. Real Recovery.

Compare centers, explore options and start your path to recovery today.

Find Treatment Now

"AddictionHelp.com is helping to make recovery available to EVERYONE!"

- Angela N.